PARP1 and neoplasm: Additionally, nicotinamide adenine dinucleotide phosphate functions as an endogenous inhibitor of ADPRylation, suppressing PARP-1-mediated DNA repair and enhancing the sensitivity of tumor cells to PARP inhibitors (Bian et al., 2019).